Your MG Patients' Top QuestionsMyasthenia gravis (MG) presents a unique set of challenges for patients. As healthcare providers (HCPs), understanding their most pressing concerns is paramount to delivering comprehensive and empathetic care.5 min read
The Road to Individualized MG TreatmentMyasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by muscle weakness and fatigue...3 min read
Differential Diagnosis: Ruling Out MimickersWhile the hallmark symptoms of myasthenia gravis (MG) are fatigue and weakness, often affecting ocular, bulbar, facial, and limb muscles...4 min read
Assessing MG Patients’ Meningococcal Vaccine StatusA comprehensive assessment of meningococcal vaccine status is paramount in MG patients. Ideally, vaccine status should be confirmed at the time of diagnosis and carefully considered in the context of planned or ongoing immunosuppressive treatments.4 min read
The Complement Cascade in gMG PathophysiologyKey Takeaways: Generalized myasthenia gravis (gMG) is characterized by fluctuating muscle weakness resulting from impaired neuromuscular transmission. While the clinical hallmark is...3 min read
Collaborative Care: Navigating Shared Decision-Making in Myasthenia GravisKey Takeaways: The management of myasthenia gravis (MG) has undergone a paradigm shift. We have moved from a limited toolkit of pyridostigmine...3 min read
Hear+Now: An AI-Powered Audio Digest - Vaccinations for MG PatientsOur latest AI audio digest features a concise discussion on the immunological considerations and clinical recommendations surrounding vaccination in MG, emphasizing key vaccines and optimal timing to bolster patient immunity while mitigating potential risks.1 min read
What Do Improvements on the MG-ADL Scale Mean for Patients?Key Takeaways: For healthcare providers (HCPs) treating patients with myasthenia gravis (MG), understanding the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale...3 min read
Targeted Symptom Management StrategiesWhile anti-cholinesterase inhibitors (AChEs) like pyridostigmine (Mestinon®) are often the first-line treatment for managing symptoms of myasthenia gravis...5 min read
Managing MG in Special PopulationsMG can affect people of any age. But its presentation, diagnosis, and management pose unique challenges in special populations, namely children, pregnant people, and the elderly.4 min read
Clinical Knowledge Assessment: MG Diagnostic & Therapeutic ChallengesChallenge your Myasthenia Gravis understanding. Take this clinical quiz for clinicians covering MG patient presentations, diagnostic pathways, and treatment considerations.1 min read
Actively Recruiting MG Clinical TrialsSeveral clinical trials are currently enrolling participants with generalized myasthenia gravis (gMG) and ocular myasthenia gravis (OMG), exploring various mechanisms of action...4 min read
Vaccinations and MG: Current RecommendationsVaccination is a critical aspect of healthcare for all individuals, and it holds particular importance for patients with myasthenia gravis (MG). Due to potential immunosuppression...3 min read
How to Identify Patients Whose gMG Symptoms Are Not Well-controlledKey Takeaways: Recognizing when generalized myasthenia gravis (gMG) symptoms are not well-controlled is vital for optimizing patient outcomes. While a range of...3 min read
Hear+Now: An AI-Powered Audio Digest – The Role of the MG-ADL Assessment to Measure Symptoms and Assess Treatment ResultsThe Myasthenia Gravis-Activities of Daily Living (MG-ADL) scale has become a cornerstone in clinical practice for quantifying symptom severity and monitoring treatment...4 min read
Empowering Patients: The Quest for Information and Better Treatment in MGIn recent years, a significant shift has occurred in myasthenia gravis (MG) care, with patients increasingly taking an active, empowered role in managing their condition.4 min read
Part 2: Myasthenia Gravis (MG) for Physicians: A Clinical ChallengeTest your Myasthenia Gravis expertise. Advanced clinical quiz for healthcare providers addressing complex MG presentations, therapy selection, and patient outcomes.1 min read
Patient Perspectives on Misunderstanding and Stigma in MGPeople living with myasthenia gravis (MG) frequently face unique challenges, particularly concerning misunderstanding and stigma.4 min read
